Stryker Corporation vs Regeneron Pharmaceuticals
Side-by-side comparison of AI visibility scores, market position, and capabilities
Stryker (SYK) reported $22.6B revenue in FY2024, up 11% YoY. Top-3 global medical device company. Leader in surgical robotics (Mako), implants, and emergency equipment. HQ: Kalamazoo, MI.
About
Stryker Corporation is one of the world's largest medical technology companies, headquartered in Kalamazoo, Michigan. Founded in 1941 by Dr. Homer Stryker as an orthopedic device company, Stryker has expanded through innovation and acquisitions into a comprehensive medical device platform. The company reported revenues of $22.6B in FY2024, up 11% year-over-year, with a market capitalization of approximately $135B.
Regeneron (REGN) reported $13.9B revenue in FY2024, up 7% YoY. Top biotech company. Dupixent franchise >$14B. Leaders in eye disease, immunology, oncology. HQ: Tarrytown, NY.
About
Regeneron Pharmaceuticals, Inc. is a leading biotechnology company specializing in the discovery, development, and commercialization of medicines for serious diseases, headquartered in Tarrytown, New York. Founded in 1988 by Leonard Schleifer and George Yancopoulos, Regeneron developed its own proprietary drug discovery technology platform (VelociGene, VelocImmune) that has enabled the development of multiple breakthrough medicines. The company reported revenues of $13.9B in FY2024, up 7% year-over-year.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.